EVEROLIMUS

49664 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking EVEROLIMUS:

# Side effect Count
0 DEATH 6375
1 MALIGNANT NEOPLASM PROGRESSION 4746
2 DIARRHOEA 4120
3 FATIGUE 3839
4 STOMATITIS 3196
5 NAUSEA 2872
6 DYSPNOEA 2648
7 DRUG INEFFECTIVE 2382
8 PYREXIA 2174
9 VOMITING 2145
See all common reactions for EVEROLIMUS

EVEROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 97 0.4059
1 ANGIOFIBROMA 26 0.3514
2 PANCREATIC NEUROENDOCRINE TUMOUR 177 0.2761
3 BRAIN STEM GLIOMA 32 0.2105
4 PIK3CA-ACTIVATED MUTATION 68 0.2048
5 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42 0.1772
6 POLYOMAVIRUS VIRAEMIA 182 0.1714
7 BLOOD CHROMOGRANIN A INCREASED 75 0.1634
8 NEUROENDOCRINE TUMOUR 227 0.1602
9 INSULINOMA 26 0.1469
See all enriched reactions for EVEROLIMUS